QS Research · Michael Burry's Scion Capital analyst template · 2006
MARSH & MCLENNAN COMPANIES, INC. (MRSH)
As of 2026-11-17 · 12/15 boxes filled from SEC filings and market data
Report price $209.88 (close 2026-11-16); latest close $206.22 (2026-11-20), -1.7% since the report; figures re-marked at the latest close
Conclusion: PASS
Conviction low · base case -17% · downside -26% · upside +12%
The market is paying 24.7x TTM net income and 3.51x TTM sales for $4.04B of post-deal net income after $9.40B of acquisitions through 2024, above the 20.1x peer median P/E. The franchise is capital-light and cash-generative, with $4.15B TTM free cash flow, but the filings describe intense competition and no durable moat, which leaves the premium multiple exposed. The base case is $170.79, or -18.6%, at the peer median P/E of 20.1x; the upside is $230.87, or +10.0%, at today's P/E of 24.7x on 10% higher earnings; and the downside is $153.71, or -26.8%, taking the base case's multiple on -10.0% earnings. With the quality real but the price already discounting durability, and the cases offering no deep-value edge, this is a PASS.
Key numbers
- Share price: $206.22
- Market cap: $98.06B
- Latest financial period: TTM to Sep 30, 2026
- Revenue (TTM): $28.46B
- P/E (TTM): 24.3x
- Earnings-quality flags (TTM): none flagged
- Revenue growth (latest fiscal year): +10.3%
The 15 boxes
- ✓ 1. Long-form business notes
Marsh makes money primarily through commissions and fees from insurance and reinsurance broking and through client, asset-based and member-based fees from consulting. The latest 10-K shows a two-segment company with $27 billion of annual revenue, more than 95,000 colleagues and a 2025 revenue mix of 64% Risk and Insurance Services / 36% Consulting; Marsh Risk alone was about 54% of revenue and Guy Carpenter about 10%. Since the FY2020 10-K, scale grew from $17 billion of revenue and 76,000 colleagues, the Risk segment share moved from about 60% to about 64%, and MMA's acquired-agency count rose from 82 to more than 135. The 2026 brand change renamed the company Marsh and the Marsh and Oliver Wyman Group businesses Marsh Risk and Marsh Management Consulting.
- ✓ 2. Competitive advantage
Marsh & McLennan shows the marks of a scale-based intermediary franchise rather than a licence or brand moat: revenue compounded from $20.72B (FY2022) to $26.98B (FY2025) and $28.46B (TTM to Sep 2026) with GAAP operating margins holding in a 20.7%-23.8% band across those years, on a very asset-light base (capex 1.1% of revenue in FY2025). What the filings say about the advantage is defensive, not proprietary: competitive conditions are described as intense in every business, with disintermediation, direct/self-insurance alternatives, banks, consultants, online platforms and generative-AI entrants named, and the consulting side (Mercer Health, investment services) facing the weakest position. The TTM period is the caution flag: revenue up 5.5% versus FY2025 but operating income down to $6.09B from $6.22B, a 21.4% margin versus 23.1%, while intangible amortization from deal-making rose to $549M in FY2025 from $377M in FY2024.
- ✓ 3. 10-Q takeaways
Q3 2026 revenue rose 8% reported and 5% underlying, with GAAP operating income up 4% and adjusted operating income up 6%; nine-month GAAP operating income fell 3% after a $569M Greensill charge. Consulting and Risk led growth while Reinsurance revenue fell 6% in the quarter. Buybacks stayed active and Thrive cost/savings targets were raised. The excerpt does not cover cash, inventory, or same-store sales.
- ✓ 4. Corporate governance
Filled; members read this box.
- ✓ 5. Overview of the prior 3 years of 8-K filings
Filled; members read this box.
- ✓ 6. Other significant filings
Filled; members read this box.
- ✓ 7. Chronology of significant news and events
Filled; members read this box.
- ✓ 8. Comparables valuation interpretation
Filled; members read this box.
- ✓ 9. Insider trading interpretation
Filled; members read this box.
- ○ 10. Earnings-call notes
- ○ 11. Impression of the shareholder letter
- ○ 12. Scuttlebutt overview
- ✓ 13. Valuation and risk/reward summary
Filled; members read this box.
- ✓ 14. Current price suppression and potential catalysts
Filled; members read this box.
- ✓ 15. Conclusions
The call above.
Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.